Thymosin Alpha1-Fc Modulates the Immune System and Down-regulates the Progression of Melanoma and Breast Cancer with a Prolonged Half-life
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thymosin Alpha1-Fc Modulates the Immune System and Down-regulates the Progression of Melanoma and Breast Cancer with a Prolonged Half-life
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-13
DOI
10.1038/s41598-018-30956-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thymosin alpha 1 and HIV-1: recent advances and future perspectives
- (2017) Claudia Matteucci et al. Future Microbiology
- Tumor-related interleukins: old validated targets for new anti-cancer drug development
- (2017) Sarra Setrerrahmane et al. Molecular Cancer
- Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK
- (2017) Walter Mandaliti et al. MOLECULES
- Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis
- (2017) Luigina Romani et al. NATURE MEDICINE
- Modern strategies and capabilities for activation of the immune response against tumor cells
- (2017) Sergey Vital’evich Sennikov et al. TUMOR BIOLOGY
- Thymosin α1 Interacts with Exposed Phosphatidylserine in Membrane Models and in Cells and Uses Serum Albumin as a Carrier
- (2016) Walter Mandaliti et al. BIOCHEMISTRY
- Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases
- (2016) F. Pica et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Fc Engineering to Improve the Function of Therapeutic Antibodies
- (2016) Futa Mimoto et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Half-life extended biotherapeutics
- (2016) Roland E. Kontermann EXPERT OPINION ON BIOLOGICAL THERAPY
- Thymosin α1 therapy subsequent to radical hepatectomy in patients with hepatitis B virus-associated hepatocellular carcinoma: A retrospective controlled study
- (2016) Yong-Rong Liang et al. Oncology Letters
- Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway
- (2015) Yan Guo et al. APOPTOSIS
- Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
- (2015) William R. Strohl BIODRUGS
- Thymosin alpha1 enhanced cytotoxicity of iNKT cells against colon cancer via upregulating CD1d expression
- (2015) Chao Ni et al. CANCER LETTERS
- IL-12 induced the generation of IL-21- and IFN-γ-co-expressing poly-functional CD4+ T cells from human naive CD4+ T cells
- (2015) Sifei Yu et al. CELL CYCLE
- Thymosin alpha-1 treatment in chronic hepatitis B
- (2015) Xiaoning Wu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
- (2013) Timo Rath et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Combination Therapy with Thymosin Alpha1 and Dexamethasone Helps Mice Survive Sepsis
- (2013) Xiao-song Xiang et al. INFLAMMATION
- CD86 Is an Activation Receptor for NK Cell Cytotoxicity against Tumor Cells
- (2013) Yanmeng Peng et al. PLoS One
- Strategies for the Production of Recombinant Protein in Escherichia coli
- (2013) Gopal Jee Gopal et al. PROTEIN JOURNAL
- Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond
- (2012) Riccardo Danielli et al. Annals of the New York Academy of Sciences
- Thymosin α1 and cancer: action on immune effector and tumor target cells
- (2012) Enrico Garaci et al. Annals of the New York Academy of Sciences
- Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?
- (2012) A. Ciancio et al. JOURNAL OF VIRAL HEPATITIS
- Strategies for extended serum half-life of protein therapeutics
- (2011) Roland E Kontermann CURRENT OPINION IN BIOTECHNOLOGY
- The effects of LY2189265, a long-acting glucagon-like peptide-1 analogue, in a randomized, placebo-controlled, double-blind study of overweight/obese patients with type 2 diabetes: the EGO study
- (2011) G. E. Umpierrez et al. DIABETES OBESITY & METABOLISM
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
- (2011) Sahar M.A. Mahmoud et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started